1. |
Terada R, Warren S, Lu JT, et al. Ablation of Nkx2.5 at mid-embr-yonic stage results in premature lethality and cardiac malformation. Cardiovasc Res, 2011, 91(2): 289-299.
|
2. |
Sizarov A, Devalla HD, Anderson RH, et al. Molecular analysis of patterning of conduction tissues in the developing human heart. Circ Arrhythm Electrophysiol, 2013, 4(4): 532-542.
|
3. |
陈轶维, 赵武, 李奋等.动脉导管未闭患儿TFAP-2B基因突变的研究.中华儿科杂志, 2010, 48(12): 900-904.
|
4. |
Vianna CB, Miura N, Pereira AC, et al. Holt-Oram syndrome:novel TBX5 mutation and associated anomalous right coronary artery. Cardiol Young, 2011, 28(10): 1-3.
|
5. |
Schott JJ, Benson DW, Basson CT, et al. Congenital heart disease caused by mutations in the transcription factor Nkx2.5. Science, 1998, 281(5): 108.
|
6. |
丁建东, 方翔, 李开如, 等.转录因子Nkx2.5和GATA4的相互作用.中国组织工程研究, 2012, 16(11): 1933-1936.
|
7. |
Ermis PR, Morales DL. The adult Fontan patient: update for 2011. Methodist Debakey Cardiovasc J, 2011, 7(2): 3-8.
|
8. |
Gong LG, Qiu GR, Jiang H, et al. Analysis of single nucleotide polymorphisms and haplotypes in HOXC gene cluster within susceptible region 12q13 of simple congenital heart disease. Chin J Med Genet, 2005, 22(50): 297-501.
|
9. |
Vianna CB, Miura N, Pereira AC, et al. Holt-Oram syndrome: novel TBX5 mutation and associated anomalous right coronary artery. Cardiol Young, 2011, 28(8): 1-3.
|
10. |
Takeuchi JK, Lou X, Alexander JM, et al. Chromatin remodelling complex dosage modulates transcription factor function in heart development. Nat Commun, 2011, 2(4): 187.
|
11. |
Martin LK, Mezentseva NV, Bratoeva M, et al. Canonical WNT signaling enhances stem cell expression in the developing heart without a corresponding inhibition of cardiogenic differentiation. Stem Cells Dev, 2011, 20(11): 1973-1983.
|
12. |
Peng T, Wang L, Zhou SF, et al. Mutations of the GATA4 and Nkx2.5 genes in Chinese pediatric patients with non-familial congenital heart disease. Genetica, 2010, 138(11): 1231-1240.
|
13. |
Butler TL, Esposito G, Blue GM, et al. GATA4 mutations in 357 unrelated patients with congenital heart malformation. Genet Test Mol Biomarkers, 2010, 14(6): 797-802.
|
14. |
Lyons I, Parsons LM, Hartley L, et al. Myogenic and morpho genetic defects in the heart tubes of murlne embryos lacking the homeobox gene Nkx2.5. Gene Dev, 1995, 9(13): 1654-1666.
|
15. |
Akazawa H, Komuro I. Cardiac transcription factor CSx/Nkx2.5: its role in cardiac development and diseases. Pharmacol Ther, 2005, 107(2): 252-268.
|
16. |
Groot AG, Bartelings M, Deruiter M, et al. Basics of cardiac develo-pment for the understanding of congenital heart malformations. Pediatr Res, 2005, 57(2): 169-176.
|
17. |
Meysen S, Marger L, Hewett KW, et al. Nkx2.5 cell-autonomous gene function is required for the postnatal formation of the peripheral ventricular conduction system. Dev Biol, 2007, 303(2): 740-753.
|
18. |
Moskowitz IP, Wang J, Peterson MA, et al. Transcription factor genes Smad4 and Gata4 cooperatively regulate cardiac valve develo-pment. Proc Natl Acad Sci USA, 2011, 108(10): 4006-4011.
|
19. |
Pashmforoush M, Lu JT, Chen H, et al. Nkx2.5 pathways and congenital heart disease:loss of ventricular myocyte lineage specifica-tion leads to progressive cardiomyopathy and complete heart block. Cell, 2004, 117(3): 373-386.
|
20. |
Kiewitz R, Lyons GE, Schafer BW, et al. Transcriptional regulation of S100A1 and expression during mouse heart development. BBA, 2000, 1498(2-3): 207-219.
|
21. |
Willingham-Rocky LA, Golding MC, Wright JM, et al. Cloning of GJA1(connexin43) and its expression in canine ovarian follicles throughout the estrous cycle. Gene ExPr Patterns, 2007, 7(1-2): 66-71.
|